Pulmonary dimorphic fungal infections among HIV / AIDS non‐TB patients with chronic cough in Kampala, Uganda
Mycoses · 2024
DOI: 10.1111/myc.13726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2024. Verfasst von Prossy Kiconco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: Cough, Sputum, HIV Infections. Die Arbeit nennt 28 Literaturangaben. Gefördert von: FIC NIH HHS, Microbiology and Immunology Training for HIV and HIV-Related Research in Uganda (MITHU) - NIH/Fogarty International Center, MAPRONANO.
Abstract (Originalsprache)
Introduction
Dimorphic fungi cause infection following the inhalation of spores into the pulmonary system. In the lower respiratory tract, the conidia transform into yeasts, which are engulfed by alveolar macrophages and may be destroyed without disease manifestation. However, in some immunocompromised individuals, they may persist and cause active fungal disease characterized by formation of granulomas in the infected tissues, which may mimic Mycobacterium tuberculosis (MTB).
Objective
To determine the prevalence of pulmonary dimorphic fungal infections among HIV/AIDS patients with non‐TB chronic cough at Mulago National Referral and Teaching Hospital in Kampala, Uganda.
Methods
Sputum samples were collected from 175 consented HIV/AIDS patients attending the immuno‐suppression syndrome (ISS) clinic at the hospital. Upon Xpert MTB/RIF sputum testing, 21 patients tested positive for MTB, and these were excluded from further analysis. The other 154 sputum negative samples were then subjected to PCR for dimorphic fungi at MBN Clinical Laboratories. Singleplex PCR was used to detect the target sequences in selected respective genes of each dimorphic fungal species of interest. DNA amplicons were detected based on gel electrophoresis.
Results
Dimorphic fungi were detected in 16.2% (25/154) of the studied population. Of these 9.1% (14/154) had Blastomyces dermatitidis and 7.1% (11/154) had Talaromyces marneffei . The remaining 84% of the studied participants had no dimorphic fungi. Histoplasma capsulatum , Coccidioides immitis and Paracoccidioides brasiliensis were not detected in any of the participants.
Conclusion
Dimorphic fungi ( B. dermatitidis and T. marneffei ) were found in 16.2% of the HIV/AIDS patients with non‐TB chronic cough in Kampala, Uganda. We recommend routine testing for these pathogens among HIV/AIDS patients with chronic cough.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
- MBN Clinical Laboratories, Kampala, Uganda.
- Department of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
ORCID-Profile: Prossy Kiconco
Förderung
- FIC NIH HHS
- Microbiology and Immunology Training for HIV and HIV-Related Research in Uganda (MITHU) - NIH/Fogarty International Center
- MAPRONANO
Zitieren
APA
Kiconco, P., Achan, B., Sanya, M., Najjingo, I., Okeng, A., & Bwanga, F. (2024). Pulmonary dimorphic fungal infections among HIV / AIDS non‐TB patients with chronic cough in Kampala, Uganda. Mycoses. https://doi.org/10.1111/myc.13726
Vancouver
Kiconco P, Achan B, Sanya M, Najjingo I, Okeng A, Bwanga F. Pulmonary dimorphic fungal infections among HIV / AIDS non‐TB patients with chronic cough in Kampala, Uganda. Mycoses. 2024. doi:10.1111/myc.13726
BibTeX
@article{Kiconco2024,
author = {Kiconco, Prossy and Achan, Beatrice and Sanya, Moses and Najjingo, Irene and Okeng, Alfred and Bwanga, Freddie},
title = {Pulmonary dimorphic fungal infections among HIV / AIDS non‐TB patients with chronic cough in Kampala, Uganda},
journal = {Mycoses},
year = {2024},
doi = {10.1111/myc.13726}
}
EUVIMED